Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD323 Antikörper

Dieses Anti--Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von in ELISA (Capture), IP, IHC und WB. Geeignet für Human.
Produktnummer ABIN2664570

Kurzübersicht für CD323 Antikörper (ABIN2664570)

Target

CD323

Reaktivität

Human

Wirt

  • 1
Maus

Klonalität

  • 1
Monoklonal

Konjugat

  • 1
Unkonjugiert

Applikation

ELISA (Capture), Immunoprecipitation (IP), Immunohistochemistry (IHC), Western Blotting (WB)

Klon

SHM33
  • Aufreinigung

    The antibody was purified by affinity chromatography.

    Isotyp

    IgG2a kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    CD323

    Hintergrund

    CD323, also known as JAM3 and JAM-C, is a member of the junctional adhesion molecule family and plays a role in leukocyte migration. It is a type I transmembrane protein and is involved in cell-cell adhesion by forming homotypic or heterotypic molecules with JAM family members or integrins. CD323 is expressed in intestinal epithelial cells and is a component of epithelial desmosomes, endothelial cells, and platelets. It is expressed at low levels on T cells and is upregulated upon activation. Due to their presence in tight junction and lateral membranes, JAMs are candidate receptors for leukocytes to use when they migrate. Thrombin induces localization of JAM3 in the tight junctions, whereas angiopoietin-1 prevents JAM3 localization.
Sie sind hier:
Chat with us!